Governor Signs Into Law Measure Requiring Coverage of Egg or Sperm Preservation

Print

Published on August 29 2018 10:52 am
Last Updated on August 29 2018 10:52 am

Young cancer patients struggling for survival no longer have to give up the prospect of parenthood when they undergo potentially sterilizing treatments such as chemotherapy, radiation or surgery.

A new law (HB 2617) signed by Gov. Bruce Rauner amends the Illinois insurance code to require coverage of egg or sperm preservation, a well-established medical practice that gives hope to patients who receive life-saving cancer treatment that they can one day have their own children. 

“Thousands of young Illinois adults of child-bearing age are diagnosed with cancer each year,” said Rauner. “With this legislation, we give them a way to overcome the burden of high out-of-pocket expenses for egg or sperm freezing so they can preserve an option to have a family in the future.”

The Oncofertility Consortium at Northwestern University was one of many health care providers who supported the precedent-setting legislation. Illinois is the third, and by far the largest, state in the U.S. to enact a law requiring insurance coverage of fertility preservation. Only Connecticut and Rhode Island have similar laws.

“Every day in Illinois, 18 young adults and children are diagnosed with cancer,” said Teresa K. Woodruff, director of the Consortium, dean of the graduate school, and Watkinsprofessor of obstetrics and gynecology at Feinberg School of Medicine.

“Today, the State of Illinois recognized that preserving fertility in the cancer setting is a medical need and that insurance should be provided to ensure young adults don’t have to choose between life-preserving treatments and fertility interventions,” she continued. “This is a win for science and more importantly, this is a win for families. This legislation will help young people and families make crucial decisions and help them afford the treatments.”

As a consequence of the Oncofertility Consortium and the organization of this new field of medicine, a cancer diagnosis is no longer associated with the fatal loss of fertility. HB 2617 demonstrates that fertility preservation has transitioned from research to standard of care. Now, young cancer patients will have access to insurance resources for their medical and fertility treatments.

HB 2617 was widely supported by local and national health advocates, medical associations, insurance providers and nonprofits. Among them were the American College of Obstetricians and Gynecologists, the American Society of Clinical Oncology, the American Society for Reproductive Medicine, the Illinois State Medical Society, Blue Cross Blue Shield of Illinois, Susan G. Komen Chicago and Gilda’s Club.